ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 154 filers reported holding ARRAY BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $5,556,000 | +100.0% | 119,925 | +5.2% | 0.00% | +50.0% |
Q1 2019 | $2,778,000 | +116.7% | 113,943 | +26.6% | 0.00% | +100.0% |
Q4 2018 | $1,282,000 | +11.6% | 89,972 | +19.0% | 0.00% | 0.0% |
Q3 2018 | $1,149,000 | -10.4% | 75,632 | -1.0% | 0.00% | 0.0% |
Q2 2018 | $1,282,000 | -2.7% | 76,399 | -5.3% | 0.00% | 0.0% |
Q1 2018 | $1,317,000 | -1.1% | 80,685 | -22.3% | 0.00% | 0.0% |
Q4 2017 | $1,331,000 | +32.8% | 103,783 | +27.2% | 0.00% | 0.0% |
Q3 2017 | $1,002,000 | +77.0% | 81,578 | +20.6% | 0.00% | – |
Q2 2017 | $566,000 | +13.2% | 67,656 | +20.6% | 0.00% | – |
Q1 2017 | $500,000 | +39.7% | 56,110 | +37.3% | 0.00% | – |
Q4 2016 | $358,000 | +145.2% | 40,854 | +76.0% | 0.00% | – |
Q3 2016 | $146,000 | +78.0% | 23,211 | 0.0% | 0.00% | – |
Q2 2016 | $82,000 | +17.1% | 23,211 | 0.0% | 0.00% | – |
Q1 2016 | $70,000 | -34.0% | 23,211 | -9.5% | 0.00% | – |
Q4 2015 | $106,000 | -11.7% | 25,657 | 0.0% | 0.00% | – |
Q3 2015 | $120,000 | -35.1% | 25,657 | 0.0% | 0.00% | – |
Q2 2015 | $185,000 | -3.6% | 25,657 | 0.0% | 0.00% | – |
Q1 2015 | $192,000 | +56.1% | 25,657 | 0.0% | 0.00% | – |
Q4 2014 | $123,000 | +28.1% | 25,657 | 0.0% | 0.00% | – |
Q3 2014 | $96,000 | – | 25,657 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
FBR & Co. | 113,500 | $706,000 | 1.07% |
Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |